CONSIDERATIONS ABOUT THE DENTAL CARE OF SELECTIVE SEROTONIN REUPTAKE INHIBITORS’ USERS
Keywords:
Antidepressants, Nonsteroidal anti-inflmatory drugs, Haemorrhage, Adverse drug reactionsAbstract
The consumption of the Selective Serotonin Reuptake Inhibitors (SSRI’s) has increased in recent years around the world. The success of these drugs is due to its efficacy and low incidence of adverse drug reactions. However, considering the increase of their use, reports of adverse drug reactions related to hemorrhage disorders, specifically in the gastrointestinal tract have also been more frequent. Even though this event seems to be rare, certain drug interactions are causing concern among medical community. Among these interactions, concomitant use of SSRI’s and nonsteroidal anti-inflammatory drugs (NSAID’s), frequently prescribed in dentistry, are of special interest and are the center of this literature review.
Downloads
References
Goldberg RJ, Selective Serotonin Reuptake Inhibitors: Infrequent medical adverse effects. Arc. Fam.Med. 1998; 7:80-84.
Bosch X, Vera M, Aplastic anaemia during treatment with fluoxetine. Lancet 1998;351:1031.
Duivestijin YCM, Kalmeijer MD, Passier ALM, Dahlen P, Smiers F. Neonatal intraventricular haemorrage associated with maternal use of paroxetine. Br. J. Clin. Pharmacol. 2003;56:581-582.
Movig KLL, Janssen MHE, Malefit JW, Kabel PJ, Leufkens HGM, Egberts ACG. Relationship of serotonergic antidepressants and need for blood transfusion in ortopedic surgical patients. Arc. Int. Med. 2003;163:2354-2358.
Van Walraven C, Mamdani MM, Wells P, Williams JI. Inhibition of serotonin reuptake by antidepressants and upper gastrointestinal bleending in elderly patients: retrospective cohort study.BMJ 2001;323:655-658.
Jong JCF, Van Den Berg PB, Tobi H, de Jong- Van Den Berg LTW. Combined use or SSRI’s and NSAID’s increases the risk of gastrointestinal adverse effects. J. Clin.Pharmacol. 2003;55:591-595.
Paton C, Ferrier NI. SSRI’s and gastrointestinal bleending: gastroprotection may be justified in some patients. BMJ 2005;331:529-530.
Serebruany VL, Selective serotonin reuptake inhibitors and increased bleeding risk: are we missing something? The American Journal of Medicine 2006;119:113- 116.
De Abajo FJ, Rodriguez LAG, Montero D, Association between serotonin reuptake inhibitors and upper gastrointestinal bleeding: population based case-control study. BMJ 1999;319:1106-1109.
Layton D, Clark DWJ, Pearce GL, Shaldir SAW. Is there an association between selective serotonin reuptake inhibitors and risk of abnormal bleeding? Eur. J. Clin. Pharmacol. 2001;57:167-176.
De Abajo FJ, Jick H, Derby L, Jick S, Schimitz S, Intracaranial haemorrhage and use of selective serotin reuptake inhibitors. J.Clin. Pharmacol.2000;50:43-47.
Bak S, Tsipoulos I, Kajaesgaard JO, Andersen M, Mellerup E, Hallas J, et al. Selective serotonin reuptake inhibitors and risk of stroke: a population-based case control study. Stroke 2002;33: 1465-1473.
Dalton SD, Johansen C, Mellemkjaer L, NÆgard B, SÆrensen HT, Olsen JH, Risk of upper gastrointestinal tract bleeding: a population-based cohrt study. Arc. Intern. Med.2003;163:59-64.
Meijer W, Heerdink ER, Nolen WA, Herings RM, Leufkens HG, Egberts A. Association of risk of abnormal bleeding with degree of serotonin reuptake inhibiton by antidepressants. Arc. Int. Med. 2004;164:2367-2370.
Serebruany VL, O’Connor CM, Grubel PA . Effect of selective serotonin reuptake inhibitors an platelets in patients with coronary artery disease. The American Journal of Cardiology 2001;87:1398-1400.
Sauer WH, Berlin JA, Kimmel SE. Effect of antidepressants and their relative affinity for the serotonin transporter on the risk of myocardial infarction, Circulation 2003;108:32-36.
Serebruany VL, Glassman AH, Malinin AI, et al. Platelet/endothelial biomarkers in depressive patients treated with the selective serotonin reuptake inhibitor sertraline after acute coronary events. Circulation 2003:108:939-944.
Meier CR, Schlienger RG, Jick H. Use of selective serotonin reuptake inhibitors and risk of developing first-time acute myocardial infarctation. Br J Clin Pharmacol.2001;52:179-184.
Tata LJ, West J, Smith C, Farrington CP, Smeeth CJ, Hubbard R. General population based study of the impact of tricyclic and selective serotonin reuptake inhibitors on the risk of acute myocardial infarctation. Heart 2005;91:465-471.
Omenn GS, Smith LT. A common uptake system for serotonin and dopamine in human platelets. J.Clin.Invest. 1978:235-240.
Shen WW, Swartz CM, Calboun JW,. Psychosomatics 1999;40:268-269.
Smith M, Robinson D. Sertraline and vaginal bleeding- a possible association. JAGS 2002;50:200-201.
Castilho LS, Perini E, Paixão HH, Prescrição de medicamentos de uso sistêmico por cirurgiões-dentistas,clínicos gerais. Rev.Saúde Pública 1999;33:287-294, 1999.
Friedlander AH, Friedlander IK, Marder SR, Posttraumatic stress dosorder:psychopathology, medical management and dental implications. Oral Surgery, Oral Medicine, Oral Pathology 2004;97:5-11.
Tata LJ, Fortun RJ, Hubbard R, Smeeth CJ, Hawkey CJ, Smiths HJ, et al. Does concurrent prescription of selective serotonin reuptake inhibitors and nonsteroidal antiinflamatory drugs substantially increase the risk of upper gastrointestinal bleeding? Aliment. Pharmacol. Ther.2005;22:175-181.
Zullino DF, Khazaal Y. Increased risk of gastrointestinal adverse effects under SSRI/ NSAID combination may due pharmacokinetic interactions. Br. J. Clin. Pharmacol. 2005;.59:118-119.
Spina E, Scordo MG, Darrigo C. Metabolic interactions with new psychotropic agents. Fundamental &Clinical Pharmacology 2003;17:517-538.
